WHO ICTRP trial
A randomised trial comparing efficacy and safety after intensification with…
EUCTR2012-003152-37-DE · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2012-003152-37-DE |
|---|---|
| Public title | A randomised trial comparing efficacy and safety after intensification with either insulin aspart once daily as add-on or changing to basal bolus treatment with insulin degludec and insulin aspart in subjects with type 2 diabetes previously treated with insulin degludec/insulin aspart twice daily |
| Scientific title | A randomised trial comparing efficacy and safety after intensification with either insulin aspart once daily as add-on or changing to basal bolus treatment with insulin degludec and insulin aspart in subjects with type 2 diabetes previously treated with insulin degludec/insulin aspart twice daily… |
| Primary sponsor | Novo Nordisk A/S |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Countries | United States;Malaysia;Turkey;Germany;Algeria |
| Conditions | Diabetes Mellitus, Type 2 MedDRA version: 14.1 Level: LLT Classification code 10045242 Term: Type II diabetes mellitus System Organ Class: 100000004861 ;Therapeutic area: Diseases [C] - Nutritional and Metabolic Diseases [C18] |
| Interventions | Product Name: IDegAsp 30 PDS290 Pharmaceutical Form: Solution for injection INN or Proposed INN: Insulin Degludec CAS Number: 8444439-96-9 Concentration unit: µmole/ml micromole(s)/millilitre Concentration type: equal Concentration number… |
| Registration date | Nov 23, 2012 |
| Target size | 97 |
| Secondary IDs | NN5401-4003 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: